Literature DB >> 19198796

[Contrast medium sonography of neuroendocrine tumors of the gastroenteropancreatic system].

Y Dörffel1, W Wermke.   

Abstract

Ultrasonography is at present the primary diagnostic imaging method in patients with abdominal complaints. The innovations in echo enhancers in the last decade in connection with improved software and hardware have substantially extended the diagnostic spectrum of ultrasonography. Thus contrast-enhanced sonography with pulse inversion technology at low mechanical index allows a continuous evaluation of the perfusion of organs and tumors. Neuroendocrine tumors represent a heterogeneous group of endodermal/epithelial tumors, which are often hypervascularized. The morphology and the perfusion behavior of neuroendocrine tumors should be known because the therapeutic options differ substantially from those of other tumors. Contrast-enhanced sonography has already proven to be a valuable alternative in the diagnosis of neuroendocrine neoplasms and their metastases in relation to the established radiological procedures.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19198796     DOI: 10.1007/s00117-008-1782-y

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  28 in total

1.  Well-differentiated pancreatic tumor/carcinoma: insulinoma.

Authors:  Wouter W de Herder; Bruno Niederle; Jean-Yves Scoazec; Stanislas Pauwels; Gunter Kloppel; Massimo Falconi; Dik J Kwekkeboom; Kjel Oberg; Barbro Eriksson; Bertram Wiedenmann; Guido Rindi; Dermot O'Toole; Diego Ferone
Journal:  Neuroendocrinology       Date:  2007-02-20       Impact factor: 4.914

Review 2.  Endocrine tumours of the gastrointestinal tract. Management of metastatic endocrine tumours.

Authors:  U Plöckinger; B Wiedenmann
Journal:  Best Pract Res Clin Gastroenterol       Date:  2005-08       Impact factor: 3.043

3.  Carcinoid tumors of the stomach: a clinical and radiographic study.

Authors:  A J Binstock; C D Johnson; D H Stephens; R V Lloyd; J G Fletcher
Journal:  AJR Am J Roentgenol       Date:  2001-04       Impact factor: 3.959

4.  MRI of carcinoid tumors: spectrum of appearances in the gastrointestinal tract and liver.

Authors:  T R Bader; R C Semelka; V C Chiu; D M Armao; J T Woosley
Journal:  J Magn Reson Imaging       Date:  2001-09       Impact factor: 4.813

5.  Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.

Authors:  H R Alexander; D L Fraker; J A Norton; D L Bartlett; L Tio; S B Benjamin; J L Doppman; S U Goebel; J Serrano; F Gibril; R T Jensen
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

6.  Carcinoid tumours. Frequency in a defined population during a 12-year period.

Authors:  T Berge; F Linell
Journal:  Acta Pathol Microbiol Scand A       Date:  1976-07

7.  Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography.

Authors:  Hubert Mörk; Andre Ignee; Gudrun Schuessler; Michaela Ott; Christoph F Dietrich
Journal:  Scand J Gastroenterol       Date:  2007-05       Impact factor: 2.423

8.  Islet cell tumors of the pancreas: pathologic-imaging correlation among size, necrosis and cysts, calcification, malignant behavior, and functional status.

Authors:  P C Buetow; T V Parrino; J L Buck; L Pantongrag-Brown; P R Ros; A H Dachman; D F Cruess
Journal:  AJR Am J Roentgenol       Date:  1995-11       Impact factor: 3.959

9.  Evaluation of diagnostic criteria for liver metastases of adenocarcinomas and neuroendocrine tumours at conventional ultrasound, unenhanced power Doppler sonography and echo-enhanced ultrasound.

Authors:  Steffen Rickes; Kenneth W Ocran; Grete Gerstenhauer; Holger Neye; Wolfram Wermke
Journal:  Dig Dis       Date:  2004       Impact factor: 2.404

10.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.